AnaptysBio's skin disease drug meets main goal in late-stage study

📆 2023-10-09 4:53 PM

Philippines News News

Philippines Latest News,Philippines Headlines

📆 2023-10-09 4:53 PM
📰 SaltWire Network

⏱ Reading Time:
9 sec. here
2 min. at publisher
📊 Quality Score:
News: 7%
Publisher: 63%

Explore stories from Atlantic Canada.

A Local Culinary Adventure: inspired by Halifax's Seaport Market | SaltWire #cooking #cookingtips - AnaptysBio Inc said on Monday its experimental drug to treat a type of rare skin disease met the main goal in a late-stage study.

The drug developer plans to submit marketing application for the drug, imsidolimab, to the U.S. Food and Drug Administration by the third quarter of 2024.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Philippines Latest News, Philippines Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

$Spain\u0027s PLD Space launches private rocket in milestone for Europe$ Spain\u0027s PLD Space launches private rocket in milestone for EuropeExplore stories from Atlantic Canada.
Read more »

Here’s where to expect the strongest winds, heaviest rain with Philippe this weekendExplore stories from Atlantic Canada.
Read more »

NL Health Services reports privacy breach of over 200 patientsExplore stories from Atlantic Canada.
Read more »

$Surging bond yields add to Canadian homeowners\u0027 mortgage pain as renewals loom$ Surging bond yields add to Canadian homeowners\u0027 mortgage pain as renewals loomExplore stories from Atlantic Canada.
Read more »

$The Buenos Aires barber\u0027s books: a history of 19,900% inflation$ The Buenos Aires barber\u0027s books: a history of 19,900% inflationExplore stories from Atlantic Canada.
Read more »